ABOVE: © ISTOCK.COM, MJ_PROTOTYPE
Antibiotic-resistant infections could kill 2.4 million people in Europe, North America, and Australia by 2050 without further action to combat the infections, according to a report released yesterday (November 7) by the Organization for Economic Cooperation and Development. But the report also says that short-term investments by governments could push back against diseases and save money in the long run.
“Drug-resistant superbugs are on the rise worldwide and represent a fundamental threat to global health and development. This report provides yet further evidence that investing to tackle the problem now will save lives and deliver big payoffs in the future,” Tim Jinks, head of the Wellcome Trust’s drug-resistant infections priority program, tells The Guardian.
Among the 36 member countries of the Organization for Economic Cooperation and Development (OECD), resistance to second- and third-line antibiotics—the most advanced drugs available to treat infections after initial rounds fail—is expected ...
